Eric Jonasch, MD, on how understanding features within the tumor microenvironment and mutated epigenetic modifying genes may provide insight on prognosis or treatment strategies in renal cell carcinoma. Website: https://www.onclive.com Twitter: / onclive Facebook: / onclive LinkedIn: / onclive